Multiparametric Mri clinical trials

Explore recruiting multiparametric mri clinical trials.

Recruiting multiparametric mri studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Multiparametric Mri trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ECETEP : Pilot study evaluating PSMA positron emission tomography for monitoring clinically significant prostate cancer after focal HIFU treatment

France

Therapeutic use (Phase IV) EU CTIS Study details

Pilot study to explore the diagnostic value of gadopiclenol in pathological and radiological insights with multiparametric MRI enhancement in breast cancer.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

[18F]-Fludarabine PET/MR Imaging for the Assessment of Newly-diagnosed Primary Central Nervous System (CNS) Lymphoma : a Pilot PET-MRI Study

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE high risk study initiative

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 clinical study to assess efficacy of Induction ipilimumab/nivolumab to spare the Bladder in urothelial bladder cancer (Indi-Blade)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

DARIUS : A RANDOMIZED NON-COMPARATIVE PHASE II MULTICENTRIC TRIAL ON SHORT TERM DAROLUTAMIDE (ODM-201) CONCOMITANT TO RADIATION THERAPY FOR PATIENTS WITH INTERMEDIATE UNFAVORABLE RISK PROSTATE CANCER

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Multiparametric Mri trials by city

Multiparametric Mri in Toronto Multiparametric Mri in Vancouver Multiparametric Mri in Montreal Multiparametric Mri in Calgary Multiparametric Mri in Edmonton Multiparametric Mri in Ottawa Multiparametric Mri in Winnipeg Multiparametric Mri in Quebec City Multiparametric Mri in Hamilton Multiparametric Mri in Kitchener Multiparametric Mri in London Multiparametric Mri in Halifax Multiparametric Mri in New York Multiparametric Mri in Los Angeles Multiparametric Mri in Chicago Multiparametric Mri in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease